Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials

Peer Review reports

Original Submission
10 Feb 2020	Submitted	Original manuscript
29 Mar 2020	Reviewed	Reviewer Report - marcus vetter
11 Apr 2020	Reviewed	Reviewer Report - Khalil Zaman
17 Apr 2020	Author responded	Author comments - Claudia Omarini
4 May 2020	Author responded	Author comments - Claudia Omarini
Resubmission - Version 2
17 Apr 2020	Submitted	Manuscript version 2
Publishing
5 May 2020	Editorially accepted
13 May 2020	Article published	10.1186/s12885-020-06933-y

Back to article page